Mayo Clinic
Rochester, Minnesota, 55905, United States
NCT Number: NCT00707616
Type 2 diabetes is a common metabolic disorder arising from a complex interaction between genetic predisposition and the environment. The development of this disorder is preceded by impaired glucose tolerance and elevated fasting glucose which also carry adverse cardiovascular risk. To date a few common genetic variants have been reliably associated with predisposition to type 2 diabetes. However, it is uncertain how these genes interact to alter insulin secretion and insulin action prior to the development of type 2 diabetes. We propose to utilize an established population-based cohort to determine how common genetic variants associated with type 2 diabetes alter the response to an oral glucose challenge in people without overt type 2 diabetes. This will enable us to understand how common variants alone or in combination alter whole-body glucose physiology and predispose to type 2 diabetes.
Looking for future studies?
Notify Me35 year–80 year
All sexes
Observational
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
one time 75g oral glucose tolerance test for measurement of insulin secretion and action
Time frame: 2 hr
Measured by 7-sample, 2Hr OGTT
Mayo Clinic
Other
The Effect of Diabetes-associated Gene Variation on Glucose Metabolism in Humans
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT03077360
Body Weight, Diabetes Mellitus
Aurora, Colorado, United States
View Trial DetailsNCT04621929
Body Weight, Glucose Intolerance
Gainesville, Florida, United States
View Trial DetailsNCT05038137
Behavior, Breast Cancer
Charleston, South Carolina, United States
View Trial Details